BioLife Solutions Engages Investors Through Upcoming Conferences
BioLife Solutions, Inc. (NASDAQ: BLFS) is setting its sights on connecting with investors as it gears up to attend several significant conferences in the upcoming months. As a prominent player in the development and supply of bioproduction products and services, BioLife is focused on the cell and gene therapy (CGT) market, with a mission to enhance the commercialization of new therapies.
Upcoming Investor Conference Participation
The management team of BioLife Solutions has confirmed attendance at the following investor conferences slated for late 2025:
Raymond James Napa Small Cap Symposium
Scheduled for November 17, this symposium offers a unique opportunity to network with other investors and industry leaders in Napa Valley. BioLife looks to leverage this event to showcase its innovations.
Stephens Annual Investment Conference
From November 18 to 20, BioLife will be present at the Stephens Annual Investment Conference in Nashville, providing a platform for discussions about the company’s trajectory and industry implications.
Jefferies Global Healthcare Conference
Following closely, from November 17 to 20, BioLife will also participate in the Jefferies Global Healthcare Conference in London. This event is known for drawing notable attention from healthcare investors and analysts.
Furey Research Partners Hidden Gems Conference
On November 24 and 25, BioLife will engage with investors virtually at the Hidden Gems Conference. This format allows for wider accessibility while fostering meaningful exchanges about the company’s goals.
Wolfe Research Small & Mid-Cap Conference
Continuing its conference agenda, BioLife will be part of the Wolfe Research conference on December 2 and 3, conducted online. This virtual setting permits in-depth discussions with investors from various geographical locations.
Northland Growth Conference
Wrapping up the investor engagement activities, BioLife plans to participate in the Northland Growth Conference on December 16, continuing to emphasize their growth and innovation in the biopharma sector.
Valuable Information for Investors
BioLife Solutions is keen on sharing insights regarding their latest initiatives and surrounding industry trends. The BioLife Investor Presentation is now available, showcasing a refreshed corporate branding strategy aligned with its vision for the future. Investors are encouraged to visit the Investor Relations section of the company's website for the latest updates and presentation materials.
About BioLife Solutions
Specializing in bioproduction, BioLife Solutions plays an essential role in the cell and gene therapy markets by providing solutions that ensure the integrity and functionality of biologic materials from development through storage and distribution. With a commitment to innovation, BioLife strives to empower the next generation of therapies while addressing critical healthcare challenges.
Contact Information
For media inquiries and further information, Troy Wichterman, Chief Financial Officer, can be reached at (425) 402-1400 or via email at twichterman@biolifesolutions.com. For investor information, Jody Cain from Alliance Advisors IR is available at (310) 691-7100 or jcain@allianceadvisors.com.
Frequently Asked Questions
What is BioLife Solutions known for?
BioLife Solutions is recognized for its development and supply of bioproduction products and services in the cell and gene therapy market.
Which conferences will BioLife Solutions attend in 2025?
BioLife Solutions will attend several conferences, including the Raymond James Napa Small Cap Symposium and the Jefferies Global Healthcare Conference, among others.
How can I access the BioLife Investor Presentation?
The latest Investor Presentation can be found in the Investor Relations section of BioLife Solutions' website.
Who can I contact for more information about BioLife Solutions?
Troy Wichterman, the Chief Financial Officer, is your contact for media inquiries, while investors can connect with Jody Cain from Alliance Advisors IR.
What is the primary goal of BioLife Solutions?
BioLife Solutions aims to facilitate the commercialization of new therapies by ensuring the health and function of biologic materials throughout their lifecycle.
